Search by Drug Name or NDC

    NDC 59779-0760-91 severe cough and cold 650; 25; 10 mg/1; mg/1; mg/1 Details

    severe cough and cold 650; 25; 10 mg/1; mg/1; mg/1

    severe cough and cold is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 59779-0760
    Product ID 59779-760_802c3df3-a092-48e2-a6e4-ab5db721b069
    Associated GPIs 43994003903045
    GCN Sequence Number 064453
    GCN Sequence Number Description diphenhyd/phenyleph/acetaminop POWD PACK 25-10-650 ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 14359
    HICL Sequence Number 035433
    HICL Sequence Number Description DIPHENHYDRAMINE HCL/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name severe cough and cold
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 25; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name CVS Pharmacy
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 59779-0760-91 (59779076091)

    NDC Package Code 59779-760-91
    Billing NDC 59779076091
    Package 6 POWDER, FOR SOLUTION in 1 CARTON (59779-760-91)
    Marketing Start Date 2010-09-14
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL e35f30da-d46d-4546-9031-92b5ca36a474 Details

    Revised: 10/2021